Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells

Published:2016-05-17 Issue:6 Volume:33 Page:521-550
ISSN:0262-0898
Container-title:Clinical & Experimental Metastasis
language:en
Short-container-title:Clin Exp Metastasis

Author:

Tachtsidis A.,McInnes L. M.,Jacobsen N.,Thompson E. W.,Saunders C. M.

Funder

National Breast Cancer Foundation

Princess Alexander Hospital Foundation

National Health and Medical Research Council

Cancer Council Western Australia

Medical Research Foundation

Department of Health, Government of Western Australia

Friends of Breast Cancer Research

Cancer Council NSW

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10585-016-9796-8.pdf

Reference301 articles.

1. DeSantis C, Ma J, Bryan L, Jemal A (2014) Breast cancer statistics, 2013. CA Cancer J Clin 64(1):52–62. doi: 10.3322/caac.21203

2. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A (2014) Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64(4):252–271. doi: 10.3322/caac.21235

3. Fidler IJ, Gersten DM, Hart IR (1978) The biology of cancer invasion and metastasis. Adv Cancer Res 28:149–250

4. Coghlin C, Murray GI (2010) Current and emerging concepts in tumour metastasis. J Pathol 222(1):1–15. doi: 10.1002/path.2727

5. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824):50–56. doi: 10.1038/3506501635065016

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study;Nature Communications;2024-03-27

2. Molecular perspectives on systemic priming and concomitant immunity in colorectal carcinoma;Journal of the Egyptian National Cancer Institute;2024-03-11

3. Inhaled anesthesia associated with reduced mortality in patients with stage III breast cancer: A population-based study;PLOS ONE;2024-03-01

4. Cellular residual disease (CRD) in early breast cancer –Expanding the concept of minimal residual disease monitoring?;The Journal of Liquid Biopsy;2024-03

5. Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?;Clinical and Experimental Medicine;2024-01-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3